US based reefer container specialist the Klinge Corporation to ramp up production as demand for specialist low temperature containers is expected to grow with the coming distribution of Covid-19 vaccines.
Vaccines tipped for approval over the coming weeks include the Pfizer/BioNtech jab, Moderna and the Oxford University/Astrazeneca injections. Of the three vaccines the Pfizer medication will be the most difficult to distribute, requiring temperatures of -70°C, while the Moderna serum will need...
https://container-news.com/klinge-corp-plans-to-ramp-up-reefer-production/